Venetoclax as a cytoreduction therapy for acute promyelocytic leukaemia: A single-centre experience

Peijing Qi1, Linya Wang1, Hongqiao Li2

  • 1Leukemia Department, Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology; National Key Clinical Discipline of Pediatric Hematology, National Key Discipline of Pediatrics (Capital Medical University); Key Laboratory of Major Diseases in Children, Ministry of Education; Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.

Abstract

No abstract available in PubMed .